A prospective, double-blind, randomized, placebo-controlled, crossover study using an orally administered oxalate decarboxylase (OxDC)
This condition can lead to persistent nausea, vomiting, and abdominal discomfort
Each operates under different regulatory frameworks with different implications for quality, legality, and safety
Many people with resistant hypertension also have obesity
Monitoring should include periodic blood chemistries, vital signs, plasma carnitine concentrations, and overall clinical condition
Healthcare providers may allow supplementation after 3 months postpartum if: The baby is healthy and developing normally The baby is healthy and developing normally Dosage is conservative Product quality and certifications are verified The supplement is not stacked with other unnecessary products This decision must always be doctor-guided